Long-term speech and language developmental issues among children with Duarte galactosemia
- PMID: 19904210
- DOI: 10.1097/GIM.0b013e3181c0c38d
Long-term speech and language developmental issues among children with Duarte galactosemia
Abstract
Purpose: : There is limited information on long-term outcomes among children with Duarte galactosemia and controversy about treatment of this potentially benign condition. This study examined developmental disabilities and issues that required special education services within a population-based sample of children with Duarte galactosemia.
Methods: : Children born between 1988 and 2001 who were diagnosed with Duarte galactosemia and resided in the five-county metropolitan Atlanta area at birth and from 3 to 10 years of age were linked to the (1) Metropolitan Atlanta Developmental Disabilities Surveillance Program, an ongoing, population-based surveillance system for selected developmental disabilities and (2) Special Education Database of Metropolitan Atlanta. Special education records were reviewed for children who linked. Clinical genetics records were reviewed to assess laboratory levels at the time of diagnosis and metabolic control during treatment.
Results: : Of the 59 eligible children, none were found to have intellectual disability, cerebral palsy, hearing loss, vision impairment, or an autism spectrum disorder. However, five, 8.5% of 3 to 10 years or 15.2% of eligible 8 years, were identified as having received special education services, four of whom were confirmed with a speech or language disorder, or were receiving services for speech or language or both compared with 4.5% and 5.9% of children without Duarte galactosemia, respectively.
Conclusions: : Despite galactose restriction until 1 year, select developmental issues associated with special education, specifically involving speech and language, have been found among some children with Duarte galactosemia.
Comment in
-
Developmental outcomes of children with Duarte galactosemia: exploring the bases of an apparent contradiction in the literature.Genet Med. 2019 Dec;21(12):2683-2685. doi: 10.1038/s41436-019-0567-1. Epub 2019 Jun 4. Genet Med. 2019. PMID: 31160755 No abstract available.
Similar articles
-
Transient developmental delays in infants with Duarte-2 variant galactosemia.Mol Genet Metab. 2021 Sep-Oct;134(1-2):132-138. doi: 10.1016/j.ymgme.2021.07.009. Epub 2021 Jul 30. Mol Genet Metab. 2021. PMID: 34391645
-
Prevalence of four developmental disabilities among children aged 8 years--Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000.MMWR Surveill Summ. 2006 Jan 27;55(1):1-9. MMWR Surveill Summ. 2006. PMID: 16437058
-
Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991.MMWR CDC Surveill Summ. 1996 Apr 19;45(2):1-14. MMWR CDC Surveill Summ. 1996. PMID: 8602136
-
Screening for speech and language delay in preschool children: systematic evidence review for the US Preventive Services Task Force.Pediatrics. 2006 Feb;117(2):e298-319. doi: 10.1542/peds.2005-1467. Pediatrics. 2006. PMID: 16452337 Review.
-
Management of developmental speech and language disorders: Part 1.Arch Dis Child. 2016 Mar;101(3):272-7. doi: 10.1136/archdischild-2014-307394. Epub 2015 Jul 24. Arch Dis Child. 2016. PMID: 26208514 Review.
Cited by
-
Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia.J Speech Lang Hear Res. 2011 Apr;54(2):487-519. doi: 10.1044/1092-4388(2010/10-0068). Epub 2010 Oct 21. J Speech Lang Hear Res. 2011. PMID: 20966389 Free PMC article.
-
Developmental Outcomes of School-Age Children with Duarte Galactosemia: A Pilot Study.JIMD Rep. 2015;19:75-84. doi: 10.1007/8904_2014_370. Epub 2015 Feb 15. JIMD Rep. 2015. PMID: 25681083 Free PMC article.
-
Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2018 Jan;20(1):3-11. doi: 10.1038/gim.2017.172. Epub 2017 Oct 26. Genet Med. 2018. PMID: 29261178
-
Newborn screening for galactosemia: a 30-year single center experience.World J Pediatr. 2015 May;11(2):160-4. doi: 10.1007/s12519-015-0017-3. Epub 2015 Mar 9. World J Pediatr. 2015. PMID: 25754754
-
Appropriateness of newborn screening for classic galactosaemia: a systematic review.J Inherit Metab Dis. 2016 Sep;39(5):633-649. doi: 10.1007/s10545-016-9936-y. Epub 2016 Apr 26. J Inherit Metab Dis. 2016. PMID: 27116003 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical